ATNF Description — 180 Life Sciences Corp
180 Life Sciences is a biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing research, and, where appropriate, combination therapy. Co.'s product development platforms that are focused on different diseases or medical conditions, and that target different factors, molecules or proteins, include: anti-tumor necrosis factor (TNF) platform, which is focusing on fibrosis and anti-TNF; synthetic cannabidiol analogs platform, which is focusing on drugs which are synthetic cannabidiol or cannabigerol analogues; and alpha 7 nicotinic acetylcholine receptor (a7nAChR) platform, which is focusing on a7nAChR.